DecisionLine Clinical research Report issue

For profit Phase 2
Founded: Toronto Canada (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
2007
NCT00751478
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now